Biomolecule fixing board and method of manufacturing the same

US9040251B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9040251-B2
Application numberUS-201013388671-A
CountryUS
Kind codeB2
Filing dateJul 29, 2010
Priority dateAug 4, 2009
Publication dateMay 26, 2015
Grant dateMay 26, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides a biomolecule modifying substrate comprising biomolecules selectively fixed to given regions thereon. The biomolecule modifying substrate comprises: a substrate at least comprising a first surface and a second surface; a first linker molecule comprising a hydrocarbon chain and a functional group capable of selectively binding to the first surface at one end of the hydrocarbon chain, which is bound to the first surface via such functional group; a second linker molecule comprising a reactive group capable of binding to the hydrocarbon chain of the first linker molecule, which is bound to the first linker molecule via a bond between the reactive group and the hydrocarbon chain; and a biomolecule bound thereto via the second linker molecule.

First claim

Opening claim text (preview).

The invention claimed is: 1. A biomolecule modifying substrate comprising: a substrate; a first surface on the substrate, the first surface comprising a metal oxide; a second surface on the substrate, the second surface comprising a noble metal; a first linker molecule comprising a hydrocarbon chain and a functional group at one end or in a side chain of the hydrocarbon chain, the functional group capable of selectively binding to the first surface, the first linker molecule bound to the first surface via the functional group; a second linker molecule comprising biotin and a reactive group, the reactive group capable of binding to the hydrocarbon chain of the first linker molecule, the second linker molecule bound to the first linker molecule via a bond between the reactive group and the hydrocarbon chain; a biomolecule comprising an introduced biotin; and an avidin, wherein the biotin contained in the second linker molecule is bound to the biotin introduced into the biomolecule via the avidin, and wherein the functional group of the first linker molecule capable of selectively binding to the first surface is a phosphate group. 2. The biomolecule modifying substrate according to claim 1 , wherein the first surface is a metal having a natural oxide film. 3. The biomolecule modifying substrate according to claim 1 , wherein the hydrocarbon chain of the first linker molecule comprises an alkyl group and is represented by the formula selected from the group consisting of C m H 2m-1 PO 3 H 2 , C m H 2m-1 OPO 3 H 2 , wherein m is an integer between 2 and 20. 4. The biomolecule modifying substrate according to claim 1 , wherein the hydrocarbon chain of the first linker molecule is a polymer chain comprising a phosphate group in the side chain of a compound represented by formula 3: wherein n is an integer of 1 or larger. 5. The biomolecule modifying substrate according to claim 1 , wherein the reactive group in the second linker molecule is a latent reactive group capable of binding to the hydrocarbon chain and the latent reactive group is at least 1 type of photoreactive compound selected from the group consisting of an anthrathione group, an anthraquinone group, a benzophenone group, an azide group, and a derivative of any thereof. 6. The biomolecule modifying substrate according to claim 1 , wherein the second linker molecule further comprises a reactive group capable of selectively binding to the biomolecule or a reactive group bound to the biomolecule. 7. The biomolecule modifying substrate according to claim 1 , wherein the first linker molecule lacks a functional group inhibiting binding between the second linker molecule and the hydrocarbon chain of the first linker molecule, and wherein the first linker molecule lacks a functional group capable of binding to the second surface. 8. The biomolecule modifying substrate according to claim 1 , wherein the hydrocarbon chain of the first linker molecule comprises an alkyl group, and wherein functional group of the second linker molecule is bonded to the alkyl group of the first linker molecule.

Assignees

Inventors

Classifications

  • with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393) · CPC title

  • Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title

  • with an insoluble carrier for immobilising immunochemicals · CPC title

  • binding through the biotin-streptavidin system or similar · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9040251B2 cover?
This invention provides a biomolecule modifying substrate comprising biomolecules selectively fixed to given regions thereon. The biomolecule modifying substrate comprises: a substrate at least comprising a first surface and a second surface; a first linker molecule comprising a hydrocarbon chain and a functional group capable of selectively binding to the first surface at one end of the hydroc…
Who is the assignee on this patent?
Tada Yasuhiko, Yoshida Hiroshi, Saito Toshiro, and 3 more
What technology area does this patent fall under?
Primary CPC classification G01N33/54353. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).